| [1] |
Meyers PA, Heller G, Healey JH, et al. Osteogenic sarcoma with clinically detectable metastasis at initial presentation[J]. J Clin Oncol,1993,11(3): 449-53.
|
| [2] |
Bacci G, Briccoli A, Mercuri M, et al. Osteosarcoma of the extremities with synchronous lung metastases: long-term results in 44 patients treated with neoadjuvant chemotherapy[J]. J Chemother, 1998,10(1):69-76.
|
| [3] |
Kager L, Zoubek A, Pötschger U, et al. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols[J]. J Clin Oncol,2003,21(10):2011-8.
|
| [4] |
Daw NC, Billups CA, Rodriguez-Galindo C, et al. Metastatic osteosarcoma[J]. Cancer,2006,106(2):403-12.
|
| [5] |
Bacci G, Briccoli A, Ferrari S, et al. Neoadjuvant chemotherapy for osteosarcoma of the extremities with synchronous lung metastases: treatment with cisplatin, adriamycin and high dose of methotrexate and ifosfamide[J]. Oncol Rep, 2000,7(2):339-46.
|
| [6] |
Winkler K, Torggler S, Beron G, et al. Results of treatment in primary disseminated osteosarcoma. Analysis of the follow-up of patients in the cooperative osteosarcoma studies COSS-80 and COSS-82[J].Onkologie, 1989,12(2):92-6.
|
| [7] |
Bacci G, Mercuri M, Briccoli A, et al. Osteogenic sarcoma of the extremity with detectable lung metastases at presentation. Results of treatment of 23 patients with chemotherapy followed by simultaneous resection of primary and metastatic lesions[J]. Cancer,1997,79(2):245-54.
|
| [8] |
Ferrari S, Briccoli A, Mercuri M, et al. Postrelapse survival in osteosarcoma of the extremities: prognostic factors for long-term survival[J]. J Clin Oncol, 2003,21(4):710-5.
|
| [9] |
Tabone MD, Kalifa C, Rodary C, et al. Osteosarcoma recurrences in pediatric patients previously treated with intensive chemotherapy[J]. J Clin Oncol,1994,12(12):2614-20.
|
| [10] |
Niu X, Zhang Q, Hao L, et al. Giant cell tumor of the extremity: retrospective analysis of 621 chinese patients from one institution[J].J Bone Joint Surg Am,2012,94(5):461-7.
|
| [11] |
Lin PP, Guzel VB, Moura MF, et al. Long-term follow-up of patients with giant cell tumor of the sacrum treated with selective arterial embolization[J].Cancer, 2002,95(6):1317-25.
|
| [12] |
Hosalkar HS, Jones KJ, King JJ, et al. Serial arterial embolization for large sacral giant-cell tumors: mid- to long-term results[J]. Spine (Phila Pa 1976),2007,32(10):1107-15.
|
| [13] |
Branstetter DG, Nelson SD, Manivel JC, et al. Denosumab induces tumor reduction and bone formation in patients with giantcell tumor of bone[J]. Clin Cancer Res,2012,18(16):4415-24.
|
| [14] |
Thomas D, Henshaw R, Skubitz K, et al. Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study[J]. Lancet Oncol, 2010,11(3):275-80.
|
下载:
